会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 22. 发明公开
    • Process for the preparation of eburnamenine oxime derivatives
    • Verfahren zur Herstellung von Eburnamenin-oxim-Derivaten。
    • EP0268245A2
    • 1988-05-25
    • EP87116885.2
    • 1987-11-16
    • SANWA KAGAKU KENKYUSHO CO., LTD.
    • Kurono, MasayasuUsui, Toshinao
    • C07D461/00
    • C07D461/00
    • A process for the preparation of an eburnamenine oxime derivative of the formula
      wherein R is an alkyl group, alkoxyalkyl group, oxylanylalkyl group, aralkyl group, aryl group, heteroaryl group,
      each of R₁ and R₂ is same or different and represents hydrogen atom, an alkyl group having 1 to 4 carbon atoms, aryl group or aralkyl group, or R₁ and R₂ may form a substituted or unsubstituted heterocyclic radical together with the neighboring nitrogen atom, and n is an integer of 2 or 3,
      which comprises a step of reacting aburnamenine thione of the formula
      with a compound of the formula
      R-ONH₂
      wherein R represents the meaning as referred to.
    • 其中R为烷基,烷氧基烷基,氧杂环烷基烷基,芳烷基,芳基,杂芳基,R 1和R 2中的每一个均为相同或不同的式CHEM的本本香碱肟衍生物的方法 并且表示氢原子,具有1至4个碳原子的烷基,芳基或芳烷基,或者R 1和R 2可以与相邻的氮原子一起形成取代或未取代的杂环基,n为2或3的整数, 其包括使式的海明ine素硫酮与式R-ONH 2的化合物反应的步骤,其中R表示所述的含义。
    • 28. 发明公开
    • APOVINCAMINIC ACID DERIVATIVE AND MEDICINE CONTAINING THE SAME
    • 阿朴氨酸衍生物和含有它的药物
    • EP0864571A1
    • 1998-09-16
    • EP95938607.9
    • 1995-11-29
    • Hidaka, Hiroyoshi
    • HIDAKA, HiroyoshiISHIKAWA, TomohikoMURAMATSU, HiroshiINOUE, Tsutomu
    • C07D461/00A61K31/435
    • C07D461/00
    • This invention relates to an apovincaminic acid derivative represented by the following formula (1):
      wherein R 1 represents a lower alkyl group, and R 2 represents an aryl group, which may be substituted by 1 to 5 substituents selected from halogen atoms and lower alkyl, lower alkoxy, lower alkoxycarbonyl, acylamino and nitro groups, a benzyl group, a quinolyl group or a thienyl group, or an acid addition salt thereof; and also to a drug containing the same. This compound has excellent vasodilating activity and platelet aggregation inhibiting activity, and can be used for the treatment of cerebrovascular disorder, thromboembolism and chronic arterial occlusive diseases and also for the improvement of blood flow disturbances.
    • 本发明涉及由下式(1)表示的阿朴长春蔓宁酸衍生物:其中R 1表示低级烷基,并且R 2表示可以被1-5个选自卤素原子和低级烷基的取代基取代的芳基,低级 烷氧基,低级烷氧羰基,酰氨基和硝基,苄基,喹啉基或噻吩基,或其酸加成盐; 还涉及含有它的药物。 该化合物具有优异的血管舒张活性和血小板凝聚抑制活性,可用于治疗脑血管障碍,血栓栓塞症和慢性动脉闭塞性疾病,也可用于改善血流紊乱。